of C. trachomatis (CT) and N. gonorrhoeae (NG), tested in HIV clinics, varied between 0% and 5%. [5] [6] [7] The prevalence among these patients in other high-income countries has not been investigated recently.
In 2007 and 2008, we studied heterosexual patients who attended the HIV outpatient clinic of the Academic Medical Center (AMC) in Amsterdam for a routine visit. The study was approved by the AMC medical ethics committee and written informed consent was obtained. Whether or not they were sexually active, patients were eligible if they were aged 18 years and older, could understand Dutch, English or
French and had not spontaneously reported STI symptoms at their routine visit. In case of spontaneously reported STI related symptoms patients were not included and referred to the STI outpatient clinic for further care. Men who indicated three or more male sexual partners in their lifetime were considered MSM and excluded.
Patients were interviewed by a trained interviewer about demographics and both sexual behaviour in the preceding 6 months and lifetime. Oral, vaginal, and anal selfswabs were obtained, 8, 9 as were serum and urine samples. If a patient's blood had been sampled less than 4 months previously, and routine care did not require new sampling, the stored blood was used for serological testing.
CT and NG were tested by Nucleic Acid Amplification Test (NAAT) (Gen-probe Aptima Assay, Tigris, San Diego, CA, USA). Serologic testing for hepatitis B and C (HBV and HCV) was performed using Axsym automated enzyme immune-assays (Abbott Our most important finding is that prevalence of asymptomatic STI is very low (1.6%) in this group of HIV-infected heterosexuals. It contrasts sharply with the 16% prevalence found in a study of HIV-infected MSM performed in the same setting, 4 and with the moderate prevalence of CT and NG found among HIV-infected women in a study done in the USA (Louisiana): 5.9% and 3.0%, respectively (7). However, in line with our findings, studies in 1999 and 2000 in the USA found a low prevalence of CT (1.7%) 5 and CT and NG (together 0.5%) (6) in HIV-infected men and women in HIV clinics. Our diagnosis of one new syphilis infection accords with other studies finding no syphilis 6 or a very low prevalence 10 in HIV-infected heterosexuals. Younger age is a risk factor for acquiring CT, 11, 12 so age differences among studies can hinder comparisons. The finding of low prevalence in our population may be explained by the low level of high-risk sexual behaviour in interviewed participants.
Recently, HCV has emerged as an STI among HIV-infected MSM. 13 However the HCV infection diagnosed in this study was most likely transmitted through needle-sharing and this suggests that HIV-infected heterosexuals are still not at risk of sexually acquired HCV.
Although other authors 14 suggested that STI screening among HIV-infected heterosexuals should be considered, our study results suggest that STI screening during routine visits of asymptomatic heterosexual patients in clinics with comparable patient groups is currently not needed. 
